Atlas Trials

Multi-day Doses in Prevention of Nausea and Emesis

Clinical trial NCT00600353 · COMPLETED

Trial details

NCT number
NCT00600353
Sponsor
University of Kansas Medical Center
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Myeloma, Plasma-CellLymphoma, Malignant
Start date
2007-10-01
Primary completion
2010-01-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.